12.05.23
L’Oréal has acquired Lactobio, a probiotic and microbiome research company based in Copenhagen—building on 20 years of advanced research by L’Oréal into the microbiome scientific territory, deepening its knowledge of the microorganisms that live on the skin’s surface and reinforcing the Groupe’s leadership in this field.
The acquisition also opens up new scientific opportunities, including leveraging Lactobio’s microbiome expertise and significant IP portfolio to develop safe and effective new cosmetic solutions using live bacteria.
These precision probiotics, created from a large biobank of lactobacillus bacteria, will be used in the development of topical formulations containing live bacteria, taking inspiration from nature to impart numerous benefits to skin and hair.
“The integration of Lactobio into our Advanced Research is highly complementary: L’Oréal’s strong scientific knowledge and technological advancements coupled with Lactobio’s best-in-class formulations using living organisms will significantly strengthen and accelerate our microbiome research dedicated to beauty,” said Anne Colonna, Global Head of Advanced Research of L’Oréal Groupe. “In joining forces, we aim to develop a new generation of cosmetics that will use cutting-edge innovations in the formulation process to provide science-based, precision probiotic and postbiotic products with new performance levels.”
“Denmark has a long history of innovation based on living microorganisms applied to food, agriculture and health, and it was against this background that we were inspired to create Lactobio,” remarked Søren Kjærulff, Founder and Chief Scientific Officer of Lactobio. “I am incredibly proud of what our team has achieved and excited for what the future holds as part of L’Oréal Groupe, where together, we can apply microbiome research to new fields of beauty innovation for people all over the world.”
In September, L’Oréal agreed to make a minority investment in Shinehigh Innovation, a biotech company in China, to establish a long-term partnership for the co-development of novel and sustainable beauty solutions.
The acquisition also opens up new scientific opportunities, including leveraging Lactobio’s microbiome expertise and significant IP portfolio to develop safe and effective new cosmetic solutions using live bacteria.
About Lactobio
Lactobio was founded in 2017 by Søren Kjærulff, Ph.D. and Charlotte Vedel, Ph.D., who developed a unique, proprietary microbiome discovery platform and screening method to select the most effective and safe strains.These precision probiotics, created from a large biobank of lactobacillus bacteria, will be used in the development of topical formulations containing live bacteria, taking inspiration from nature to impart numerous benefits to skin and hair.
“The integration of Lactobio into our Advanced Research is highly complementary: L’Oréal’s strong scientific knowledge and technological advancements coupled with Lactobio’s best-in-class formulations using living organisms will significantly strengthen and accelerate our microbiome research dedicated to beauty,” said Anne Colonna, Global Head of Advanced Research of L’Oréal Groupe. “In joining forces, we aim to develop a new generation of cosmetics that will use cutting-edge innovations in the formulation process to provide science-based, precision probiotic and postbiotic products with new performance levels.”
“Denmark has a long history of innovation based on living microorganisms applied to food, agriculture and health, and it was against this background that we were inspired to create Lactobio,” remarked Søren Kjærulff, Founder and Chief Scientific Officer of Lactobio. “I am incredibly proud of what our team has achieved and excited for what the future holds as part of L’Oréal Groupe, where together, we can apply microbiome research to new fields of beauty innovation for people all over the world.”
More L’Oréal News
In November, L’Oréal announced an exclusive partnership with Cosmo International Fragrances to bring a Green Sciences-based extraction process to revolutionize the art of fine fragrance creation.In September, L’Oréal agreed to make a minority investment in Shinehigh Innovation, a biotech company in China, to establish a long-term partnership for the co-development of novel and sustainable beauty solutions.
